We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$1.93M
Cap. Flow
+$1.8M
Cap. Flow %
1.6%
Top 10 Hldgs %
21.04%
Holding
61
New
2
Increased
51
Reduced
8
Closed
–

Top Buys

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$2.01M
2
TRP icon
TC Energy
TRP
+$1.86M
3
ABBV icon
AbbVie
ABBV
+$36.2K
4
SCHW
Charles Schwab
SCHW
+$30.9K
5
AFL icon
Aflac
AFL
+$30.9K

Top Sells

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$1.61M
2
CVX icon
Chevron
CVX
+$628K
3
CVS icon
CVS Health
CVS
+$302K
4
LMT icon
Lockheed Martin
LMT
+$270K
5
TD icon
Toronto Dominion Bank
TD
+$147K

Sector Composition

Rank Sector Weight
1 Financials 22.24%
2 Healthcare 16.91%
3 Industrials 12.85%
4 Technology 10.72%
5 Energy 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
26
Pfizer
PFE
$152B
$1.94M 1.73%
37,435
+521
+1% +$27K
EMN icon
27
Eastman Chemical
EMN
$8.55B
$1.9M 1.69%
16,955
+226
+1% +$26.5K
TSN icon
28
Tyson Foods
TSN
$19.9B
$1.9M 1.69%
21,189
+284
+1% +$25.9K
ENB icon
29
Enbridge
ENB
$113B
$1.89M 1.68%
40,961
+539
+1% +$23.1K
DGX icon
30
Quest Diagnostics
DGX
$26.2B
$1.89M 1.68%
13,773
+182
+1% +$25.4K
HUBB icon
31
Hubbell
HUBB
$27.5B
$1.89M 1.68%
10,260
+137
+1% +$25.7K
LMT icon
32
Lockheed Martin
LMT
$138B
$1.87M 1.66%
4,229
-666
-14% -$270K
PSX icon
33
Phillips 66
PSX
$89.5B
$1.82M 1.62%
21,109
+191
+0.9% +$16.1K
AES icon
34
AES
AES
$10.5B
$1.82M 1.62%
70,582
+953
+1% +$21.5K
KEY icon
35
KeyCorp
KEY
$24.3B
$1.81M 1.62%
81,064
+1,075
+1% +$26.7K
VZ icon
36
Verizon
VZ
$196B
$1.81M 1.61%
35,581
+477
+1% +$25.3K
SNA icon
37
Snap-on
SNA
$21.3B
$1.81M 1.61%
8,791
+116
+1% +$24.5K
LOW icon
38
Lowe's Companies
LOW
$124B
$1.79M 1.59%
8,857
+108
+1% +$24.8K
ORI icon
39
Old Republic International
ORI
$10.2B
$1.76M 1.57%
68,042
+902
+1% +$23.3K
PFG icon
40
Principal Financial Group
PFG
$24.2B
$1.76M 1.57%
23,978
+326
+1% +$23.6K
BBY icon
41
Best Buy
BBY
$17.6B
$1.7M 1.52%
18,722
+242
+1% +$24K
WBA
42
DELISTED
Walgreens Boots Alliance
WBA
$1.7M 1.51%
37,932
+511
+1% +$25.1K
BMY icon
43
Bristol-Myers Squibb
BMY
$130B
$1.68M 1.49%
22,978
+349
+2% +$23.4K
SJM icon
44
J.M. Smucker
SJM
$12.5B
$1.66M 1.48%
12,249
+160
+1% +$21.8K
JNJ icon
45
Johnson & Johnson
JNJ
$626B
$1.63M 1.45%
9,189
+128
+1% +$21.8K
BEN icon
46
Franklin Resources
BEN
$16.9B
$1.62M 1.44%
57,989
+786
+1% +$24K
TFC icon
47
Truist Financial
TFC
$63.9B
$1.6M 1.43%
28,292
+379
+1% +$23.4K
JPM icon
48
JPMorgan Chase
JPM
$962B
$1.59M 1.42%
11,665
+159
+1% +$23.5K
UGI icon
49
UGI
UGI
$7.54B
$1.57M 1.4%
43,441
+578
+1% +$23.1K
MDT icon
50
Medtronic
MDT
$116B
$1.57M 1.4%
14,159
+184
+1% +$19.4K
1
2
3

Similar funds

ANBOT
American National Bank of Texas Richardson, Texas $105M AUM
P
Palladiem Bryn Mawr, Pennsylvania $105M AUM
SHF
Safe Harbor Fiduciary Pensacola, Florida $105M AUM
SDP
Sentinel Dome Partners Burlingame, California $105M AUM
MAM
McLaughlin Asset Management Danville, Illinois $105M AUM
AF
Aldebaran Financial $105M AUM 19.84% 1-Year Est. Return
EEL
Expect Equity LLC Pikesville, Maryland $104M AUM 40.12% 1-Year Est. Return
BC
Bayhunt Capital Mill Valley, California $106M AUM

Weaver C. Barksdale & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Weaver C. Barksdale & Associates held 61 positions worth $112M, up 1.8% from $110M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 3.3%. Weaver C. Barksdale & Associates opened 2 new positions and made no exits, leaving the 61-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Weaver C. Barksdale & Associates's largest Q1 2022 buy was EOG Resources: 18,035 shares worth $2.15M.
  • Weaver C. Barksdale & Associates added most to AbbVie in Q1 2022, an estimated $36.2K increase.
  • Weaver C. Barksdale & Associates's biggest Q1 2022 reduction was Marathon Petroleum, cutting an estimated $1.61M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 21% of its $112M portfolio in Q1 2022.
  • Weaver C. Barksdale & Associates opened 2 new positions and closed 0 in Q1 2022.
  • Weaver C. Barksdale & Associates's portfolio value rose 1.8% quarter-over-quarter to $112M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2022, filed 16 May 2022.